28.07.2017

Alkaloid AD Skopje achieved positive financial results in the period January-June 2017 - shows the unaudited standalone and unaudited consolidated Income Statement.

According to the unaudited standalone Income Statement, in the period January- June the sales reached the amount of MKD 3,507,290,746 - 8% up on the same period last year. Earnings before interest, taxes, depreciation and amortization (EBITDA), which amount to MKD 649,689,157 marked an increase of roughly 11%, whereas the net profit amounting to MKD 374,886,745 rose by 9%.

In the period January - June the total consolidated sales reached MKD 4,554,009,259 - an increase of 9% compared to the same period last year. Consolidated sales in the domestic market increased by 7%, while the total consolidated export of the company increased by 10%. Out of the total consolidated sales, 39% were realized in the domestic market, while the foreign markets account for 61%. The breakdown by region shows that the countries of South-East Europe account for 32% of the sales, Russia and CIS - 7%, 21% of the sales were realized in the countries from Western Europe (EU and EFTA), while the other markets account for 1% of the total consolidated sales. Noticeable rise was seen in Great Britain reaching sales of MKD 127,873,079 and Hungary with sales of MKD 11,691,735 - both increased by 18 times compared to the same period last year. Growth in sales was also marked in the following export markets: Russia - 24%, Romania - 52%, Slovenia - 24%, Ukraine - 33%, Montenegro - 17% etc.

The breakdown of total consolidated sales by group of products shows that the best sellers are the products from the segment Pharmaceuticals - 84%, with OTC products accounting for 21%, cardiovascular products - 16%, antibiotics - 14%, neurological products - 13% etc. The Chemistry Cosmetics Botanicals segment accounts for 16% of the total consolidated sales, or more precisely Chemistry - 3%, Cosmetics - 10% and Botanicals - 3%.

Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA), which reached MKD 668,995,343 saw an increase of 12%, whereas the net consolidated profit amounting to MKD 361,750,584 went up by 11%.

The total investments in non-current assets for the period January - June 2017 amounted to MKD 323,470,022.

In the period January - June 2017 Alkaloid recruited 54 new employees in the Republic of Macedonia.

Alkaloid AD Skopje published this content on 28 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 28 July 2017 08:38:05 UTC.

Original documenthttp://www.alkaloid.com.mk/investor-news-ns_article-alkaloid-growth-in-sales.nspx

Public permalinkhttp://www.publicnow.com/view/E1BCEF9B6FD1B3DC56C3BA41986B8D2432551BBD